PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hypotension D007022 41 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Hyperalgesia D006930 42 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Leukemia P388 D007941 43 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Precancerous Conditions D011230 48 associated lipids
Thrombosis D013927 49 associated lipids
Osteosarcoma D012516 50 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Aukema HM et al. Dietary fish oil reduces glomerular injury and elevated renal hydroxyeicosatetraenoic acid levels in the JCR:LA-cp rat, a model of the metabolic syndrome. 2013 Br. J. Nutr. pmid:23151363
Neely SM et al. Mechanism and characteristics of platelet activation by haematin. 1984 Br. J. Haematol. pmid:6383458
Pacienza N et al. 15-deoxy-Delta(12,14)-PGJ(2) induces cell cycle arrest and apoptosis of haematopoietic progenitors. 2010 Br. J. Haematol. pmid:19764987
Pan IQ et al. Alteration of platelet responses to metabolites of arachidonic acid by oral contraceptives. 1984 Br. J. Haematol. pmid:6089860
Heilmann S et al. No genetic support for a contribution of prostaglandins to the aetiology of androgenetic alopecia. 2013 Br. J. Dermatol. pmid:23448296
Massey WA et al. Profile of prostanoid release following antigen challenge in vivo in the skin of man. 1991 Br. J. Dermatol. pmid:1760357
Koro O et al. Release of prostaglandin D2 and histamine in a case of localized heat urticaria, and effect of treatments. 1986 Br. J. Dermatol. pmid:2432916
Hensby CN et al. Prostaglandins in human skin disease. 1983 Br. J. Dermatol. pmid:6574787
Nishida K et al. Inhibition of human chondrosarcoma cell growth via apoptosis by peroxisome proliferator-activated receptor-gamma. 2002 Br. J. Cancer pmid:11953889
Chearwae W and Bright JJ PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells. 2008 Br. J. Cancer pmid:19018263
Siavash H et al. Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d-PGJ(2) in oral squamous carcinoma cells. 2004 Br. J. Cancer pmid:15316561
Nikitakis NG et al. 15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells. 2002 Br. J. Cancer pmid:12454768
Matsuo T and Cynader MS The EP2 receptor is the predominant prostanoid receptor in the human ciliary muscle. 1993 Br J Ophthalmol pmid:8435410
Goh Y et al. Prostaglandin D2 reduces intraocular pressure. 1988 Br J Ophthalmol pmid:3164634
Rees MC and Kelly RW Prostaglandin D2 release by endometrium and myometrium. 1986 Br J Obstet Gynaecol pmid:3466645
Barr RM et al. The in vitro 5-lipoxygenase and cyclo-oxygenase inhibitor L-652,343 does not inhibit 5-lipoxygenase in vivo in human skin. 1988 Br J Clin Pharmacol pmid:2835975
Johnston SL et al. The effects of an oral thromboxane TP receptor antagonist BAY u 3405, on prostaglandin D2- and histamine-induced bronchoconstriction in asthma, and relationship to plasma drug concentrations. 1992 Br J Clin Pharmacol pmid:1467134
Scadding GK et al. Effect of short-term treatment with fluticasone propionate nasal spray on the response to nasal allergen challenge. 1994 Br J Clin Pharmacol pmid:7893587
al Jarad N et al. Effects of a thromboxane receptor antagonist on prostaglandin D2 and histamine induced bronchoconstriction in man. 1994 Br J Clin Pharmacol pmid:8148229
Wood-Baker R et al. The reproducibility and effect on non-specific airway responsiveness of inhaled prostaglandin D2 and leukotriene D4 in asthmatic subjects. 1995 Br J Clin Pharmacol pmid:7742148
Stellato C et al. General anaesthetics induce only histamine release selectively from human mast cells. 1991 Br J Anaesth pmid:1722691
Yue L et al. Prostaglandin D(2) induces apoptosis of human osteoclasts through ERK1/2 and Akt signaling pathways. 2014 Bone pmid:24345643
Lin TH et al. PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats. 2007 Bone pmid:17669705
Hounoki H et al. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression. 2008 Bone pmid:18242157
Yue L et al. Prostaglandin D2 induces apoptosis of human osteoclasts by activating the CRTH2 receptor and the intrinsic apoptosis pathway. 2012 Bone pmid:22705147
Seckl J Mechanisms of fetal origins of health problems in adults need to be investigated. 1998 BMJ pmid:9665923
Garg TK and Chang JY 15-deoxy-delta 12, 14-Prostaglandin J2 prevents reactive oxygen species generation and mitochondrial membrane depolarization induced by oxidative stress. 2004 BMC Pharmacol. pmid:15149553
Garg TK and Chang JY Oxidative stress causes ERK phosphorylation and cell death in cultured retinal pigment epithelium: prevention of cell death by AG126 and 15-deoxy-delta 12, 14-PGJ2. 2003 BMC Ophthalmol pmid:12659653
Nakahata Y et al. The in vitro real-time oscillation monitoring system identifies potential entrainment factors for circadian clocks. 2006 BMC Mol. Biol. pmid:16483373
Le Loupp AG et al. Activation of the prostaglandin D2 metabolic pathway in Crohn's disease: involvement of the enteric nervous system. 2015 BMC Gastroenterol pmid:26338799
Jeong KT et al. Anti-allergic effect of a Korean traditional medicine, Biyeom-Tang on mast cells and allergic rhinitis. 2014 BMC Complement Altern Med pmid:24521096
Chaffer CL et al. PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma. 2006 BMC Cancer pmid:16519808
Bertelé V et al. Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase products. 1984 Blood pmid:6426554
Watanabe T et al. Characterization of prostaglandin and thromboxane receptors expressed on a megakaryoblastic leukemia cell line, MEG-01s. 1991 Blood pmid:1718495
Ishii T et al. Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders. 2009 Blood pmid:19196660
Payne SG et al. The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors. 2007 Blood pmid:17008548
Reddy RC et al. Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-{gamma}. 2008 Blood pmid:18535203
Piva R et al. 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins. 2005 Blood pmid:15498850
Cooper B Diminished platelet adenylate cyclase activation by prostaglandin D2 in acute thrombosis. 1979 Blood pmid:380688
Hasegawa H et al. A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Delta 12, 14 prostaglandin J2 production. 2007 Blood pmid:17551094
Appel S et al. PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. 2005 Blood pmid:16105976
Piliponsky AM et al. Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. 2003 Blood pmid:12393403
Ko FN et al. YC-1, a novel activator of platelet guanylate cyclase. 1994 Blood pmid:7527671
O'Brien JJ et al. 15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes. 2008 Blood pmid:18755987
Wang LH et al. Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP. 2007 Blood pmid:17785586
Rajakariar R et al. Novel biphasic role for lymphocytes revealed during resolving inflammation. 2008 Blood pmid:18218853
Zhang X et al. Peroxisome proliferator-activated receptor-gamma and its ligands attenuate biologic functions of human natural killer cells. 2004 Blood pmid:15265789
Monneret G et al. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. 2001 Blood pmid:11535533
Akbiyik F et al. Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes. 2004 Blood pmid:15130939
Zhang X et al. Unexpected sensitivity of synthetic Renilla luciferase control vectors to treatment with a cyclopentenone prostaglandin. 2003 BioTechniques pmid:14682047
Suzuki K and Uyeda M Inhibitory properties of antitumor prostaglandins against topoisomerases. 2002 Biosci. Biotechnol. Biochem. pmid:12353631
Komoda T and Nishikawa M 6'-Hydroxyoxosorbicillinol, a new lipoxygenase inhibitor and PGD2/LTB4 release suppressor from Penicillium sp. 2012 Biosci. Biotechnol. Biochem. pmid:22785490
Moulin D et al. Effect of peroxisome proliferator activated receptor (PPAR)gamma agonists on prostaglandins cascade in joint cells. 2006 Biorheology pmid:16912428
Pedersen PJ et al. Prostaglandin phospholipid conjugates with unusual biophysical and cytotoxic properties. 2010 Bioorg. Med. Chem. Lett. pmid:20591667
Kim S et al. Synthesis of 15R-PGD2: a potential DP2 receptor agonist. 2005 Bioorg. Med. Chem. Lett. pmid:15780624
Nicoll-Griffith DA et al. In vitro biotransformations of the prostaglandin D2 (DP) antagonist MK-0524 and synthesis of metabolites. 2007 Bioorg. Med. Chem. Lett. pmid:17095220
Usui S et al. Design, synthesis, and biological activity of novel PPARgamma ligands based on rosiglitazone and 15d-PGJ2. 2005 Bioorg. Med. Chem. Lett. pmid:15745794
Wang Y et al. Optimization of phenylacetic acid derivatives for CRTH2 and DP selective antagonism. 2012 Bioorg. Med. Chem. Lett. pmid:22119474
Sato A et al. Synthesis and evaluation of 2,3-dinorprostaglandins: Dinor-PGD1 and 13-epi-dinor-PGD1 are peroxisome proliferator-activated receptor α/γ dual agonists. 2013 Bioorg. Med. Chem. Lett. pmid:23566516
Pande V and Ramos MJ Molecular recognition of 15-deoxy-delta(12,14)-prostaglandin J2 by nuclear factor-kappa B and other cellular proteins. 2005 Bioorg. Med. Chem. Lett. pmid:16006125
Dang HT et al. New jasmonate analogues as potential anti-inflammatory agents. 2008 Bioorg. Med. Chem. pmid:18996699
Shram SI et al. [Preparation and properties of prostaglandin D2 labelled with tritium with high molar radioactivity]. 1989 Bioorg. Khim. pmid:2590255
Nakamura M et al. Tumor apoptosis in prostate cancer by PGD(2) and its metabolite 15d-PGJ(2) in murine model. 2013 Biomed. Pharmacother. pmid:23206752
Kohno S et al. Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma. 2006 Biomed. Pharmacother. pmid:16337105
Maekawa N et al. High-performance affinity purification for identification of 15-deoxy-Δ 12,14 -PGJ₂ interacting factors using magnetic nanobeads. 2011 Biomed. Chromatogr. pmid:21374648
Martins CA et al. Malva sylvestris L. extract suppresses desferrioxamine-induced PGEâ‚‚ and PGDâ‚‚ release in differentiated U937 cells: the development and validation of an LC-MS/MS method for prostaglandin quantification. 2014 Biomed. Chromatogr. pmid:24403179
Huang L et al. 15d-PGJ2 Reduced Microglia Activation and Alleviated Neurological Deficit of Ischemic Reperfusion in Diabetic Rat Model. 2015 Biomed Res Int pmid:26844229
Harizi H The immunobiology of prostanoid receptor signaling in connecting innate and adaptive immunity. 2013 Biomed Res Int pmid:24024207
Schoppee PD et al. Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. 2002 Biol. Reprod. pmid:11751282
Cheuk BL et al. Cyclooxygenase-2 regulates apoptosis in rat epididymis through prostaglandin D2. 2002 Biol. Reprod. pmid:11804951
AL-Hader AA et al. Novel expression of functional luteinizing hormone/chorionic gonadotropin receptors in cultured glial cells from neonatal rat brains. 1997 Biol. Reprod. pmid:9116153
Desmarais JA et al. The peroxisome proliferator-activated receptor gamma regulates trophoblast cell differentiation in mink (Mustela vison). 2007 Biol. Reprod. pmid:17615406
Ackerman WE et al. Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFkappaB signal disruption in human WISH and amnion cells. 2005 Biol. Reprod. pmid:15843495
Komar CM and Curry TE Inverse relationship between the expression of messenger ribonucleic acid for peroxisome proliferator-activated receptor gamma and P450 side chain cleavage in the rat ovary. 2003 Biol. Reprod. pmid:12700202
Pradhan A and Olsson PE Juvenile ovary to testis transition in zebrafish involves inhibition of ptges. 2014 Biol. Reprod. pmid:24920039
Ohishi K et al. Increased level of salivary prostaglandins in patients with major depression. 1988 Biol. Psychiatry pmid:3422573
Mooney JJ et al. Signal transduction by platelet adenylate cyclase: alterations in depressed patients may reflect impairment in the coordinated integration of cellular signals (coincidence detection). 1998 Biol. Psychiatry pmid:9564442
Nishino S et al. Prostaglandin E2 levels in cerebrospinal fluid of normal and narcoleptic dogs. 1990 Biol. Psychiatry pmid:2268692
Wang M et al. The Responses of Pulmonary and Systemic Circulation and Airway to Allergic Mediators in Anesthetized Rats. 2016 Biol. Pharm. Bull. pmid:27040628
Jin MH et al. Anti-inflammatory activity of Ailanthus altissima in ovalbumin-induced lung inflammation. 2006 Biol. Pharm. Bull. pmid:16651713
Son JK et al. Ginkgetin, a Biflavone from Ginko biloba leaves, inhibits cyclooxygenases-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. 2005 Biol. Pharm. Bull. pmid:16327145
Chang TS et al. NQ-Y15 inhibits the calcium mobilization by elevation of cyclic AMP in rat platelets. 2001 Biol. Pharm. Bull. pmid:11379764
Lu Y et al. Manassantin B isolated from Saururus chinensis inhibits cyclooxygenase-2-dependent prostaglandin D2 generation by blocking Fyn-mediated nuclear factor-kappaB and mitogen activated protein kinase pathways in bone marrow derived-mast cells. 2013 Biol. Pharm. Bull. pmid:23719635
Li X et al. Natural vanadium-containing Jeju groundwater inhibits immunoglobulin E-mediated anaphylactic reaction and suppresses eicosanoid generation and degranulation in bone marrow derived-mast cells. 2012 Biol. Pharm. Bull. pmid:22293352
Tsuji T et al. Differential effects of beta2-adrenoceptor desensitization on the IgE-dependent release of chemical mediators from cultured human mast cells. 2004 Biol. Pharm. Bull. pmid:15467193
Reanmongkol W et al. Inhibitory effect of alkaloids extracted from the stem bark of Hunteria zeylanica on 5-lipoxygenase activity in vitro. 1995 Biol. Pharm. Bull. pmid:7550132
Tanaka Y et al. Enhanced release of prostaglandin D2 during re-incubation of RAW 264.7 macrophage-like cells after treatment of both lipopolysaccharide and non-steroidal anti-inflammatory drugs. 2004 Biol. Pharm. Bull. pmid:15256727
Lee E et al. Anti-asthmatic activity of an ethanol extract from Saururus chinensis. 2006 Biol. Pharm. Bull. pmid:16462020
Kitatani K et al. Role of phospholipase D-derived phosphatidic acid as a substrate for phospholipase A2 in RBL-2H3 cells. 2000 Biol. Pharm. Bull. pmid:11145171
Numazawa S et al. Possible involvement of transient receptor potential channels in electrophile-induced insulin secretion from RINm5F cells. 2012 Biol. Pharm. Bull. pmid:22382320
Takei M et al. Role of cyclic AMP during histamine release. Histamine release is not directly related to increase in cyclic AMP levels in rat mast cells activated by concanavalin A, anti-IgE, antigen, prostaglandin D2 and isoproterenol. 1988 Biol. Chem. Hoppe-Seyler pmid:2463844
Dieter P et al. 4-Bromophenacyl bromide inhibits prostaglandin D2 synthesis from arachidonic acid rather than phospholipase A2 activity in liver macrophages. 1989 Biol. Chem. Hoppe-Seyler pmid:2775481
Safaralizadeh R et al. Influence of selenium on mast cell mediator release. 2013 Biol Trace Elem Res pmid:23784732
Cutler LS et al. Cytochemical localization of adenylate cyclase in the dense tubule system of human blood platelets stimulated by forskolin, prostacyclin and prostaglandin D2. 1985 Biochim. Biophys. Acta pmid:3890960
Asano T et al. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation. 2000 Biochim. Biophys. Acta pmid:10838168
Gates D et al. Apo J/clusterin expression and secretion: evidence for 15-deoxy-Δ(12,14)-PGJ(2)-dependent mechanism. 2012 Biochim. Biophys. Acta pmid:22138303
O'Flaherty JT et al. 5-Oxo-ETE analogs and the proliferation of cancer cells. 2005 Biochim. Biophys. Acta pmid:16154383
Ohara H et al. Reduction of prostaglandin D2 to 9 alpha,11 beta-prostaglandin F2 by a human liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase isozyme. 1994 Biochim. Biophys. Acta pmid:7948008
Suzuki F et al. Methyl ester of prostaglandin D2 as a delivery system of prostaglandin D2 into brain. 1987 Biochim. Biophys. Acta pmid:3467795
Hayashi H et al. Metabolism of prostaglandin D2 in isolated rat lung: the stereospecific formation of 9 alpha,11 beta-prostaglandin F2 from prostaglandin D2. 1987 Biochim. Biophys. Acta pmid:3467796